Best of ASCO - 2014 Annual Meeting

 

Welcome

Palliative Care and Symptom Management

Patient and Survivor Care

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A multi-center, randomized, double-blinded, placebo-controlled trial of additive effect of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: JORTC- PAL08 (DIRECT study).

Eriko Satomi

10102

A phase iia trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.

Ting Bao

e22201

A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN).

Thomas J. Smith

e22206

A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy.

Tanya B. Dorff

TPS10132

A randomized phase II study of the nutritional and exercise treatment for the elderly patients with advanced non-small cell lung or pancreatic cancer: The NEXTAC-TWO study.

Satoru Miura

TPS10131

A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of health-related quality of life and metabolic events in patients with advanced breast cancer treated with everolimus.

Somedeb Ball

e22219

A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hypophosphatemia, hypertension, and hematological toxicities in patients with cancer treated with regorafenib.

Henry Palangdao Igid

e22218

Acupuncture RCT in patients with GI cancer cachexia: A pilot study.

Saunjoo Yoon

e22209

Adapalene gel 0.1% vs. placebo as prophylaxis for anti-EGFR-induced acne-like rash: A randomized left-right comparative evaluation (APPEARANCE).

Motoko Tachihara

10093

An effective anti-emetic regimen for less than $2 USD: A prospective observational study.

Nikita Mehra

e22194

Artificial nutrition in palliative care cancer patients.

Bernard Lobato Prado

e22190

Association between phase angle and survival in patients with advanced cancer admitted to an acute palliative care unit (APCU).

David Hui

10023

Barriers to early integration of palliative care: A qualitative analysis of medical oncologist attitudes and practice patterns.

Tim J Kruser

e22191

Barriers to palliative care (PC) utilization in hematopoietic stem cell transplantation (HCT).

Areej El-Jawahri

10116

Celiac plexus radiosurgery: A new palliative modality for upper gastrointestinal malignancies—Final results of a proof-of-concept clinical trial.

Yaacov Richard Lawrence

10098

Chemotherapy-induced-fatigue and gene expression profile in peripheral blood mononuclear cells of breast cancer patients receiving adjuvant or neoadjuvant chemotherapy.

Auro Del Giglio

e22168

Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project.

Vicente Guillem

e22175

Communication near the end of life (EoL) between oncologists and patients with advanced cancer in Mexico.

Jacqueline Alcalde-Castro

e22192

Community-based palliative care utilization in elderly pancreatic cancer patients.

Zhanni Lu

10108

Comparison of efficacy and safety of biosimilar filgrastim in a RCT (PIONEER) and real-world practice (MONITOR-GCSF).

Nadia Harbeck

111

Comparison of oxaliplatin-related spleen enlargement in patient with gastric cancer who received S-1 versus capecitabine as a combination partner of oxaliplatin.

Seyoung Seo

e22195

Comparisons of palliative care utilization in metastatic cancer patients between multi-payer non-universal health care and single-payer universal health care systems.

Raymond Nienchen Kuo

10110

Coping with long-lasting incurable cancer: An ethnographic study in a comprehensive cancer centre.

Hilde Buiting

e22214

Correlation between serum iron levels increased by chemotherapy and chemotherapy-induced nausea and vomiting.

Toshimichi Miya

e22170

Cryocompression for enhanced limb hypothermia in preventing paclitaxel-induced peripheral neuropathy.

Raghav Sundar

10095

CYP2D6 phenotype and tramadol-related adverse events in breast cancer patients.

Nikola Besic

e22186

Determinants of quality of life and survival in ambulatory oncology patients receiving chemotherapy.

Derek Gerard Power

10120

Discrepancy between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: A post-hoc analysis (WJOG4407GSS2).

Yuji Miura

e22165

Does cytotoxic chemotherapy (CT) have a role in palliative treatment of hepatocellular carcinoma (HCC)?

Guilherme Nader Marta

10114

Does timing of palliative care consults impact end-of-life health services utilization in pancreatic cancer patients?

Nizar Bhulani

10006

Early palliative care interventions in patients with glioblastoma.

Prakash Ambady

e22203

Effect of minocycline on symptom burden and inflammation markers in patients with colorectal cancer: A randomized phase II trial.

Xin Shelley Wang

e22176

Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial.

Federica Mazzuca

TPS10129

Effect of pre-treatment sleep disturbance on radiation therapy (RT)-induced pain in 676 women with breast cancer.

Anita Roselyn Peoples

10100

Effects of mindfulness meditation on quality of life in adults with advanced cancer and family caregivers: A randomized pilot.

Shelley A. Johns

10096

Effects of strong cytochrome P450 (CYP)3A4 inducers/inhibitors on the pharmacokinetic (PK) profile of anamorelin in healthy volunteers.

Elizabeth Duus

e22180

Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study.

Veerisa Vimolchalao

10019

Efficacy of an intravenous formulation of NEPA, a fixed combination of fosnetupitant and palonosetron, compared with oral NEPA studies in the prevention of chemotherapy-induced nausea and vomiting (CINV): An analysis of 1026 patient experiences.

Eric Roeland

e22177

Efficacy of omega-3 (ω3) supplementation versus omega-6 (ω6) supplementation for reducing pain among breast cancer survivors: A URCC NCORP RCT.

Luke Joseph Peppone

10118

Evaluation of a mobile application to prepare and engage cancer patients prior to a palliative care (PC) visit: Results of a randomized, controlled trial.

Arif Kamal

10103

Exercise counseling in integrative oncology: Patient characteristics and effects on self-reported symptoms.

Gabriel Lopez

10089

Experience with the implant of vascular access devices by medical oncologist in a non-surgical scenery.

Alfonso Revuelta

e22202

Gaps in palliative care provision among the Indian cancer centres.

Anuja Damani

e22181

Gut microbiome alterations in breast cancer survivors with cancer-related fatigue.

Alexandre Chan

e22178

Home hospice care and its genesis in Nepal.

Rashmey Pun

e22164

Impact of education about early palliative care (ePC) and a tool for timely identification of eligible patients on a clinical trial (CT) of ePC.

Susanne Zwahlen

e22211

Impact of oncologist outpatient productivity on prevalence of goals of care discussions.

Sofya Pintova

10106

Incidence and predictors of hypoalbuminemia in Indian patients with breast and cervical cancer.

Anubha Bharthuar

e22197

Incidence of dermatological toxicities and fatigue in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials.

Miguel Quirch

10123

Incidence of pneumonitis in patients with solid tumors treated with everolimus: A systematic review and meta- analysis of randomized controlled trials.

Kyaw Zin Thein

e22220

Incorporating geriatric patient reported outcomes into novel screening tool of distress and supportive care concerns.

Christine B. Weldon

10115

Intensive 4-weeks’ mindfulness therapy in the treatment of chronic pain in patients with cancer: Pilot study.

Anna Kieszkowska-Grudny

10121

Length of time to conduct goals of care visits.

Sofya Pintova

10107

Longitudinal patient-reported symptom severity and symptom interference with activity-related and mood-related functioning and survival in patients with advanced cancer on early-phase clinical trials of immunotherapeutic or targeted agents.

Goldy George

10119

Malignant wounds associated with cancer: Delay in treatment, impairment in quality of life and associated psychosocial and financial burden.

Brooke E Rosenbaum

e22171

Nasal vestibulitis: An under-recognized and under-treated side effect of cancer treatment.

Gaurav Goyal

e22172

Nutritional parameters for nutritional intervention as predictive factors in patients with metastatic esophageal squamous cell cancer.

Hiromichi Shirasu

e22185

Olanzapine and palonosetron without dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: A proof-of-concept trial.

Hee Jun Kim

e22204

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Sherry Shen

10000

Oncology patient and practitioner experience with complementary/alternative medicine at the NIH Clinical Center.

Tara A. Berman

e22188

Opioid use in rural breast cancer patients.

Emilio Paul Araujo-Mino

10124

Outcomes after pericardial window surgery (PWS) for palliation of malignant pericardial effusion (MPE).

Raúl Alejandro López Saucedo

e22193

Pain after curative treatment for breast cancer.

Catherine J. Datto

e22200

Patient reported outcomes (PRO) results for prophylactic effect of dexamethasone on regorafenib-related fatigue and/or malaise: a randomized, placebo-controlled, double-blind clinical study in patients with unresectable metastatic colorectal cancer: KSCC1402/HGCSG1402.

Mototsugu Shimokawa

10094

Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients.

Johnny Hoang

10111

Patterns and determinants of pain and emotional distress in older adults with cancer: A population based study.

Amy J. Davidoff

10105

Patterns of palliative care utilization in stage IV non-small cell lung cancer in the National Cancer Database.

Urshila Durani

10109

PG2 injection, a novel botanical drug approved for improving cancer-related fatigue among advanced cancer patients under standard palliative care: A double blind, multi-center, randomized phase IV study.

Cheng-Hsu Wang

10091

Pharmacological management of cancer cachexia: A systematic review.

Shailesh M Advani

e22169

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

Antony Mersiades

TPS10128

Place of death in gastrointestinal cancer patients: Retrospective study in Japanese general hospital.

Toshihiko Matsumoto

e22189

Post-operative breast pain in an ethnically diverse population.

Tamie L. Kerns

e22183

Pretreatment physical activity to predict short- and long-term chemotherapy-induced peripheral neuropathy (CIPN) in a nationwide longitudinal study of paclitaxel for breast cancer.

Ian Kleckner

10018

Prophylactic treatment for acneiform rash caused by EGFR inhibitors: Prospective randomized double-blind trial comparing daily topical chloramphenicol 3% plus prednisolone 0.5% vs chloramphenicol 3% vs aqua cream.

Salomon M. Stemmer

10092

Prospsective phase II pilot study to evaluate the use of intravenous iron in the treatment of anemia in cancer patients.

Youjin Kim

10113

Psychosocial distress among cancer patients: A single institution experience at the state of Qatar.

Azza Adel Hassan

e22163

Quality of life(QoL) outcomes including neuropathy associated scale (FACT-T) from a phase II, multicenter, randomized trial of eribulin plus gemcitabine(EG) versus paclitaxel plus gemcitabine(PG) as first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)- negative metastatic breast cancer(MBC): Korean Cancer Study Group trial (KCSG BR13-11).

Ji-Yeon Kim

10117

Racial disparities in palliative and hospice care beliefs of lung cancer patients.

Aditya Varnam Shreenivas

10104

Randomized controlled trial of percutaneous transesophageal gastrotubing for symptom palliation in patients with malignant gastrointestinal obstruction.

Miyuki Sone

10090

Randomized trial of a symptom monitoring intervention for hospitalized patients with cancer.

Charn-Xin Fuh

10005

Randomized, double-blind, phase III trial of monosialotetrahexosylganglioside versus placebo in GI cancer patients with oxaliplatin induced peripheral neurotoxicity (TJMUCH-GI-001).

Zhou Likun

10017

Relationships between immune cell profiles and frailty in patients with breast cancer from pre- to post- chemotherapy: A University of Rochester NCI community oncology research program prospective, longitudinal study.

Nikesha Gilmore

10099

Resident's attitudes and beliefs towards palliative care in a community teaching hospital.

Sufana Shikdar

e22187

Results of an educational tool for residents and referring physicians on palliative radiation for bone metastases.

Nina Desai

e22167

Retrospective cohort study comparing hydration protocols with or without mannitol in patients treated with cisplatin (HYDRA study).

Nathalie LeTarte

10021

REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal (IP) bevacizumab (bev) for recurrent ascites in advanced, chemotherapy-resistant, epithelial ovarian cancer (CR-EOC).

Katrin Marie Sjoquist

10097

Risk of gastrointestinal and hepatic toxicities in patients with advanced breast cancer treated with everolimus: A meta- analysis of phase 3 randomized controlled trials.

Sriman Swarup

e22215

Risk stratification using patient-reported outcomes (PROs) in patients (pts) with advanced cancer.

Shiven B. Patel

10101

Rose geranium in sesame oil nasal spray: A potential treatment for nasal vestibulitis?

Elizabeth Jane Cathcart-Rake

e22166

Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.

Charles L. Loprinzi

10016

Sensor-controlled scalp cooling for chemotherapy-induced alopecia: Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and/or taxanes in the neoadjuvant or adjuvant setting.

Christian M. Kurbacher

e22196

Symptom burden in hospitalized patients with curable and incurable cancers.

Richard Newcomb

10004

The antidiarrheal efficacy of a proprietary amino acid mixture (enterade) in neuroendocrine tumor (NET) patients.

Aman Chauhan

e22217

The association of serum ghrelin, GIP, insulin, and leptin levels with sleep quality and cancer-related fatigue in cancer survivors.

Po-Ju Lin

10122

The effect of acupuncture versus cognitive behavior therapy on insomnia in cancer survivors: A randomized clinical trial.

Jun J. Mao

10001

The impact of pain in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients.

Hannah Woopen

10112

The stability and variations in the reporting of the CAGE-AID screening questionnaire among patients with advanced cancer.

Tonya Edwards

e22198

Treating anorexia in people with advanced cancer. a randomised, double blind, controlled trial of megestrol acetate, dexamethasone or placebo.

David Christopher Currow

10020

Using patient-reported outcomes measures to tailor care for complex cancer survivors: A feasibility study of HN-STAR.

Talya Salz

e22210

Voice of cancer patients (VoCP): Use and experience of acupuncture in cancer patients.

Sangeeta Aggarwal

e22216